| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
 India |  China | India | China | India | China | India | China | India | China | |
| Diabetes estimates (20-79 y) | ||||||||||
| People with diabetes, in 1,000s | 32,674.4 | 22,564.8 | 61,258.4 | 90,045.1 | 74,194.7 | 140,869.6 | 92,973.7 | 164,069.5 | 124,874.7 | 174,433.5 |
| Age-adjusted comparative prevalence of diabetes, % | - | - | 9.0 | 8.8 | 9.6 | 10.6 | 10.4 | 11.8 | 10.8 | 12.5 |
| People with undiagnosed diabetes, in 1,000s | - | - | - | - | 39,397.4 | 72,839.5 | - | - | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | - | - | 53.1 | 51.7 | - | - | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | ||||||||||
| People with IGT, in 1,000s | - | - | 20,467.5 | 23,373.0 | 40,143.8 | 169,869.6 | 50,045.4 | 190,686.1 | 65,557.3 | 196,056.9 |
| Age-adjusted comparative prevalence of IGT, % | - | - | 3.0 | 2.3 | 5.4 | 13.4 | 5.6 | 14.2 | 5.8 | 14.7 |
| Mortality attributable to diabetes (20-79 y) | ||||||||||
| Deaths attributable to diabetes | - | - | 983,203.0 | 1,133,918.0 | 647,831.0 | 1,396,661.8 | - | - | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | 2.8 | 3.9 | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | ||||||||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 18.1 | 5.3 | 0.0 | 0.0 | 19.2 | 4.9 | - | - | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | 24.0 | 6.1 | - | - | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 66.9 | 25.6 | - | - | 124.6 | 29.6 | - | - | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | 229.4 | 56.0 | - | - | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||||||||
| Live births affected by HIP | - | - | - | - | 6,182,373.9 | 1,463,241.6 | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | 29.3 | 8.6 | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | 220,541.9 | 164,353.6 | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | 194,791.2 | 160,847.9 | - | - | - | - |
| Diabetes-related health expenditure | ||||||||||
| Total diabetes-related health expenditure, USD million | - | - | - | - | 8,485.8 | 165,304.0 | 10,305.5 | 185,008.2 | 12,834.3 | 193,142.7 |
| Total diabetes-related health expenditure, ID million | - | - | - | - | 32,054.9 | 308,528.5 | 38,928.6 | 345,305.0 | 48,481.1 | 360,487.6 |
| Diabetes-related health expenditure per person, USD | - | - | 68.0 | 194.0 | 114.4 | 1,173.5 | 138.9 | 1,313.3 | 173.0 | 1,371.1 |
| Diabetes-related health expenditure per person, ID | - | - | - | - | 432.0 | 2,190.2 | 524.7 | 2,451.2 | 653.4 | 2,559.0 |
| Demographics | ||||||||||
| Total adult population (20-79 y), in 1,000s | 567,714.0 | 847,913.0 | 737,003.3 | 968,974.9 | 893,910.0 | 1,079,960.8 | 1,022,119.2 | 1,105,921.3 | 1,154,012.2 | 1,066,546.2 |
| Population of children (0-14 y), in 1,000s | 361,182.0 | 350,695.0 | - | - | 359,208.6 | 254,115.2 | - | - | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | - | - | 485,464.9 | 336,356.3 | - | - | - | - |
| Impaired fasting glucose (IFG) estimates (20-79 y) | ||||||||||
| People with IFG, in 1,000s | - | - | - | - | 75,123.9 | 26,935.0 | 85,065.3 | 29,517.7 | 95,598.7 | 29,639.8 |
| Age-adjusted comparative prevalence of IFG, % | - | - | - | - | 7.8 | 2.2 | 8.2 | 2.3 | 8.3 | 2.4 |
| Complications of diabetes | India | China | ||||||||
| Microvascular | ||||||||||
| Nephropathy | 5.9% | - | ||||||||
| Retinopathy | 0.8% | - | ||||||||
| Neuropathy | 10.6% | - | ||||||||
| Macrovascular | ||||||||||
| Coronary artery disease | 2.5% | - | ||||||||
| Cerebrovascular disease | 0.3% | - | ||||||||
| Peripheral artery disease | 0.0% | - | ||||||||
| Heart failure | 0.2% | - | ||||||||